135 related articles for article (PubMed ID: 12489119)
1. Mutagenic activity of cisplatin in the lacZ plasmid-based transgenic mouse model.
Louro H; Silva MJ; Boavida MG
Environ Mol Mutagen; 2002; 40(4):283-91. PubMed ID: 12489119
[TBL] [Abstract][Full Text] [Related]
2. Treatment of lacZ plasmid-based transgenic mice with benzo[a]pyrene: measurement of DNA adduct levels, mutant frequencies, and mutant spectra.
Boerrigter ME
Environ Mol Mutagen; 1999; 34(2-3):140-7. PubMed ID: 10529738
[TBL] [Abstract][Full Text] [Related]
3. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells.
Silva MJ; Costa P; Dias A; Valente M; Louro H; Boavida MG
Environ Mol Mutagen; 2005 Aug; 46(2):104-15. PubMed ID: 15887215
[TBL] [Abstract][Full Text] [Related]
5. DNA adducts, mutant frequencies, and mutation spectra in various organs of lambda lacZ mice exposed to ethylating agents.
Mientjes EJ; Luiten-Schuite A; van der Wolf E; Borsboom Y; Bergmans A; Berends F; Lohman PH; Baan RA; van Delft JH
Environ Mol Mutagen; 1998; 31(1):18-31. PubMed ID: 9464312
[TBL] [Abstract][Full Text] [Related]
6. Background mutations and polymorphisms in lacZ-plasmid transgenic mice.
Dollé ME; Snyder WK; van Orsouw NJ; Vijg J
Environ Mol Mutagen; 1999; 34(2-3):112-20. PubMed ID: 10529734
[TBL] [Abstract][Full Text] [Related]
7. Detecting genotoxic effects of potential clastogens: an in vivo study using the transgenic lacZ plasmid and the MutaMouse model.
Mahabir AG; van Benthem J; Korsten H; Lynch AM; Bailey L; de Vries A; Hendriksen CF; van Steeg H
Mutat Res; 2008 Apr; 652(2):151-7. PubMed ID: 18387846
[TBL] [Abstract][Full Text] [Related]
8. High sensitivity for color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection.
Boerrigter ME
Environ Mol Mutagen; 1998; 32(2):148-54. PubMed ID: 9776177
[TBL] [Abstract][Full Text] [Related]
9. Temporal and molecular characteristics of lacZ mutations in somatic tissues of transgenic mice.
Douglas GR; Jiao J; Gingerich JD; Soper LM; Gossen JA
Environ Mol Mutagen; 1996; 28(4):317-24. PubMed ID: 8991059
[TBL] [Abstract][Full Text] [Related]
10. Nitrogen-substitution effect on in vivo mutagenicity of chrysene.
Yamada K; Suzuki T; Kohara A; Kato TA; Hayashi M; Mizutani T; Saeki K
Mutat Res; 2005 Sep; 586(1):1-17. PubMed ID: 16054434
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of mitomycin C-induced large deletions and tandem-base substitutions in the bone marrow of gpt delta transgenic mice.
Takeiri A; Mishima M; Tanaka K; Shioda A; Ueda O; Suzuki H; Inoue M; Masumura K; Nohmi T
Chem Res Toxicol; 2003 Feb; 16(2):171-9. PubMed ID: 12588188
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of spontaneous mutations in liver tissue of lacI transgenic mice.
de Boer JG; Erfle H; Walsh D; Holcroft J; Provost JS; Rogers B; Tindall KR; Glickman BW
Environ Mol Mutagen; 1997; 30(3):273-86. PubMed ID: 9366905
[TBL] [Abstract][Full Text] [Related]
13. Induction of A:T to G:C transition mutations by 5-(2-chloroethyl)-2'-deoxyuridine (CEDU), an antiviral pyrimidine nucleoside analogue, in the bone marrow of Muta Mouse.
Staedtler F; Suter W; Martus HJ
Mutat Res; 2004 Dec; 568(2):211-20. PubMed ID: 15542108
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen causes gene mutations in the livers of lambda/lacI transgenic rats.
Davies R; Oreffo VI; Martin EA; Festing MF; White IN; Smith LL; Styles JA
Cancer Res; 1997 Apr; 57(7):1288-93. PubMed ID: 9102215
[TBL] [Abstract][Full Text] [Related]
15. Sources of variability in mutant frequency determinations in different organs of lacZ plasmid-based transgenic mice: experimental features and statistical analysis.
Boerrigter ME; Vijg J
Environ Mol Mutagen; 1997; 29(3):221-9. PubMed ID: 9142164
[TBL] [Abstract][Full Text] [Related]
16. Mutant frequencies and spectra depend on growth state and passage number in cells cultured from transgenic lacZ-plasmid reporter mice.
Busuttil RA; Rubio M; Dollé ME; Campisi J; Vijg J
DNA Repair (Amst); 2006 Jan; 5(1):52-60. PubMed ID: 16126462
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of induction of DNA damage and lacZ gene mutations in stomach mucosa of mice treated with beta-propiolactone and N-methyl-N'-nitro-N-nitrosoguanidine, using single-cell gel electrophoresis and MutaMouse models.
Brault D; Renault D; Tombolan F; Thybaud V
Environ Mol Mutagen; 1999; 34(2-3):182-9. PubMed ID: 10529742
[TBL] [Abstract][Full Text] [Related]
18. Mutation spectrum in UVB-exposed skin epidermis of a mildly-affected Xpg-deficient mouse.
Wang F; Saito Y; Shiomi T; Yamada S; Ono T; Ikehata H
Environ Mol Mutagen; 2006 Mar; 47(2):107-16. PubMed ID: 16247763
[TBL] [Abstract][Full Text] [Related]
19. Plasmid-based transgenic mouse model for studying in vivo mutations.
Boerrigter ME; Dollé ME; Martus HJ; Gossen JA; Vijg J
Nature; 1995 Oct; 377(6550):657-9. PubMed ID: 7566182
[TBL] [Abstract][Full Text] [Related]
20. Frequency and spectrum of lacI mutations in the liver of Big Blue mice following the administration of genotoxic carcinogens singly and in series.
Delker DA; Geter DR; Kleinert KM; Gollapudi BB
Int J Toxicol; 2008; 27(1):35-42. PubMed ID: 18293211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
